Choline alfoscerate is a drug used to improve cerebrovascular diseases and brain metabolism. It is a drug with proven safety, which has no effect on the kidney and liver and with no severe side effect reported. When administered to a patient with muscle cramps, it can significantly reduce pain and the occurrence of muscle cramps. Accordingly, it may be used as an active ingredient in a pharmaceutical composition for treating or preventing muscle cramps and a health functional food composition for improving muscle cramps and may also be used for a method for treating muscle cramps by administering choline alfoscerate. In addition, choline alfoscerate may also be used to prepare a medication for treating muscle cramps.

The present invention relates to a cocoa composition comprising at least 2 weight % of cocoa solids and less than 5 weight % of milk solids, and characterized in that it comprises 0.5-20% of a bulking ingredient and 0.5-10% of a plasticizers ingredient. Food products comprising the cocoa composition described are also provided, for example, bakery products, confectionary products, and dairy-alternative products.

The present invention relates to a cocoa composition comprising at least 2 weight % of cocoa solids and less than 5 weight % of milk solids, and characterized in that it comprises 0.5-20% of a bulking ingredient and 0.5-10% of a plasticizers ingredient. Food products comprising the cocoa composition described are also provided, for example, bakery products, confectionary products, and dairy-alternative products.

The present invention relates to a chocolate composition comprising at least 30 weight % of cocoa solids and less than 2 weight % of milk solids, based on the total weight of the chocolate composition, characterized in that it further comprises 0.5-15 weight % plant-based protein and 0.5-10 weight % of a plasticizer ingredient, wherein the chocolate composition is substantially free from soy protein.

The present invention relates to a chocolate composition comprising at least 30 weight % of cocoa solids and less than 2 weight % of milk solids, based on the total weight of the chocolate composition, characterized in that it further comprises 0.5-15 weight % plant-based protein and 0.5-10 weight % of a plasticizer ingredient, wherein the chocolate composition is substantially free from soy protein.

The present invention relates to a cocoa composition comprising less than 5 weight % of milk solids, characterized in that it comprises 0.5-15 weight % of a pea-based protein and 0.5-10 weight % of a plasticizer ingredient. Also provided are food products comprising the cocoa composition described, for example bakery products, confectionary products, and dairy-alternative products.

The present invention relates to a cocoa composition comprising less than 5 weight % of milk solids, characterized in that it comprises 0.5-15 weight % of a pea-based protein and 0.5-10 weight % of a plasticizer ingredient. Also provided are food products comprising the cocoa composition described, for example bakery products, confectionary products, and dairy-alternative products.

The present invention relates to a cocoa composition comprising at least 30 weight % sucrose and less than 5 weight % of milk solids, characterized in that it comprises 0.5-15 weight % of a plant-based protein other than soy protein, and 0.5-20 weight % of a bulking ingredient. Food products comprising the cocoa composition described are also provided, for example, bakery products, confectionary products, and dairy-alternative products.

The present invention relates to a cocoa composition comprising at least 30 weight % sucrose and less than 5 weight % of milk solids, characterized in that it comprises 0.5-15 weight % of a plant-based protein other than soy protein, and 0.5-20 weight % of a bulking ingredient. Food products comprising the cocoa composition described are also provided, for example, bakery products, confectionary products, and dairy-alternative products.

Disclosed are nutritional compositions including human milk oligosaccharides that can be administered to preterm infants, term infants, toddlers, and children for improving airway defense mechanisms.